Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Transverse Tibial Bone Transport (TTT) in the Management of Chronic Diabetic Lower Extremity Wounds

NCT: NCT07444593 · NOT_YET_RECRUITING

NCT IDNCT07444593
StatusNOT_YET_RECRUITING
Start Date2026-05-01
Completion2027-02-28

Brief Summary

The purpose of this study is to evaluate the safety and clinical performance of transverse tibial bone transport in patients with chronic ischemic and diabetic lower extremity ulcers. This study will assess wound healing outcomes and limb preservation in a population with limited therapeutic alternatives.

Frequently Asked Questions

What is Transverse Tibial Bone Transport (TTT) in the Management of Chronic Diabetic Lower Extremity Wounds?

Transverse Tibial Bone Transport (TTT) in the Management of Chronic Diabetic Lower Extremity Wounds is a clinical trial registered under NCT07444593. Current status: NOT_YET_RECRUITING.

What is the status of NCT07444593?

The current status of NCT07444593 (Transverse Tibial Bone Transport (TTT) in the Management of Chronic Diabetic Lower Extremity Wounds) is: NOT_YET_RECRUITING.

When did Transverse Tibial Bone Transport (TTT) in the Management of Chronic Diabetic Lower Extremity Wounds start?

Transverse Tibial Bone Transport (TTT) in the Management of Chronic Diabetic Lower Extremity Wounds started on 2026-05-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑